These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Different susceptibility to 1-methyl-4-phenylpyridium (MPP(+))-induced nigro-striatal dopaminergic cell loss between C57BL/6 and BALB/c mice is not related to the difference of monoamine oxidase-B (MAO-B). Ito T; Suzuki K; Uchida K; Nakayama H Exp Toxicol Pathol; 2013 Jan; 65(1-2):153-8. PubMed ID: 21855308 [TBL] [Abstract][Full Text] [Related]
23. Selegiline can mediate neuronal rescue rather than neuronal protection. Tatton WG Mov Disord; 1993; 8 Suppl 1():S20-30. PubMed ID: 8302304 [TBL] [Abstract][Full Text] [Related]
24. Characterization of organotypic ventral mesencephalic cultures from embryonic mice and protection against MPP toxicity by GDNF. Jakobsen B; Gramsbergen JB; Møller Dall A; Rosenblad C; Zimmer J Eur J Neurosci; 2005 Jun; 21(11):2939-48. PubMed ID: 15978005 [TBL] [Abstract][Full Text] [Related]
25. (+)MK-801 prevents the DDC-induced enhancement of MPTP toxicity in mice. Vaglini F; Fascetti F; Fornai F; Maggio R; Corsini GU Brain Res; 1994 Dec; 668(1-2):194-203. PubMed ID: 7704605 [TBL] [Abstract][Full Text] [Related]
26. Toxic effects of MPP(+) and MPTP in PC12 cells independent of reactive oxygen species formation. Fonck C; Baudry M Brain Res; 2001 Jun; 905(1-2):199-206. PubMed ID: 11423095 [TBL] [Abstract][Full Text] [Related]
27. Deprenyl antagonizes acute lethality of 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine in mice. Fuller RW; Hemrick-Luecke SK; Perry KW J Pharmacol Exp Ther; 1988 Nov; 247(2):531-5. PubMed ID: 3141609 [TBL] [Abstract][Full Text] [Related]
28. Different effects of monoamine oxidase inhibition on MPTP depletion of heart and brain catecholamines in mice. Fuller RW; Hemrick-Luecke SK; Kindt MV; Heikkila RE Life Sci; 1988; 42(3):263-71. PubMed ID: 3121972 [TBL] [Abstract][Full Text] [Related]
29. Inhibition of transcription factor SP1 produces neuroprotective effects through decreasing MAO B activity in MPTP/MPP Yao L; Dai X; Sun Y; Wang Y; Yang Q; Chen X; Liu Y; Zhang L; Xie W; Liu J J Neurosci Res; 2018 Oct; 96(10):1663-1676. PubMed ID: 30004136 [TBL] [Abstract][Full Text] [Related]
30. 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced neuroblastic apoptosis in the subventricular zone is caused by 1-methy-4-phenylpiridinium (MPP(+)) converted from MPTP through MAO-B. Ito T; Suzuki K; Uchida K; Nakayama H Exp Toxicol Pathol; 2012 Nov; 64(7-8):761-5. PubMed ID: 21324658 [TBL] [Abstract][Full Text] [Related]
31. Role of the redox protein thioredoxin in cytoprotective mechanism evoked by (-)-deprenyl. Andoh T; Chock PB; Murphy DL; Chiueh CC Mol Pharmacol; 2005 Nov; 68(5):1408-14. PubMed ID: 16099847 [TBL] [Abstract][Full Text] [Related]
32. Role of neuronal nitric oxide in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP)-induced dopaminergic neurotoxicity. Przedborski S; Jackson-Lewis V; Yokoyama R; Shibata T; Dawson VL; Dawson TM Proc Natl Acad Sci U S A; 1996 May; 93(10):4565-71. PubMed ID: 8643444 [TBL] [Abstract][Full Text] [Related]
33. In brown Norway rats, MPP+ is accumulated in the nigrostriatal dopaminergic terminals but it is not neurotoxic: a model of natural resistance to MPTP toxicity. Zuddas A; Fascetti F; Corsini GU; Piccardi MP Exp Neurol; 1994 May; 127(1):54-61. PubMed ID: 8200437 [TBL] [Abstract][Full Text] [Related]
34. The mesolimbic dopaminergic pathway is more resistant than the nigrostriatal dopaminergic pathway to MPTP and MPP+ toxicity: role of BDNF gene expression. Hung HC; Lee EH Brain Res Mol Brain Res; 1996 Sep; 41(1-2):14-26. PubMed ID: 8883930 [TBL] [Abstract][Full Text] [Related]
35. Increased susceptibility of G-protein coupled receptor 6 deficient mice to MPTP neurotoxicity. Oeckl P; Ferger B Neuroscience; 2016 Nov; 337():218-223. PubMed ID: 27651149 [TBL] [Abstract][Full Text] [Related]
36. A model of chronic neurotoxicity: long-term retention of the neurotoxin 1-methyl-4-phenylpyridinium (MPP+) within catecholaminergic neurons. Johannessen JN Neurotoxicology; 1991; 12(2):285-302. PubMed ID: 1956587 [TBL] [Abstract][Full Text] [Related]
37. Tetrahydrobiopterin precursor sepiapterin provides protection against neurotoxicity of 1-methyl-4-phenylpyridinium in nigral slice cultures. Madsen JT; Jansen P; Hesslinger C; Meyer M; Zimmer J; Gramsbergen JB J Neurochem; 2003 Apr; 85(1):214-23. PubMed ID: 12641743 [TBL] [Abstract][Full Text] [Related]
38. EGb761 protects against nigrostriatal dopaminergic neurotoxicity in 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine-induced Parkinsonism in mice: role of oxidative stress. Rojas P; Serrano-García N; Mares-Sámano JJ; Medina-Campos ON; Pedraza-Chaverri J; Ogren SO Eur J Neurosci; 2008 Jul; 28(1):41-50. PubMed ID: 18662333 [TBL] [Abstract][Full Text] [Related]
39. Lowering ambient or core body temperature elevates striatal MPP+ levels and enhances toxicity to dopamine neurons in MPTP-treated mice. Moy LY; Albers DS; Sonsalla PK Brain Res; 1998 Apr; 790(1-2):264-9. PubMed ID: 9593931 [TBL] [Abstract][Full Text] [Related]
40. Structure-neurotoxicity trends of analogues of 1-methyl-4-phenylpyridinium (MPP+), the cytotoxic metabolite of the dopaminergic neurotoxin MPTP. Arora PK; Riachi NJ; Fiedler GC; Singh MP; Abdallah F; Harik SI; Sayre LM Life Sci; 1990; 46(5):379-90. PubMed ID: 2304377 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]